secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scinai Immunotherapeutics Ltd. (SCNI)
CIK:        0001611747
Form:       8-K
Filed at:   2023-05-04T23:59:59+00:00
Accession:  0001213900-23-036129
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BiondVax publishes investor presentation on May 4, 2023; no financial results disclosed
--------------------------------------------------------------------------------

- Presentation made available on company website and discussed in meetings starting May 4, 2023.
- Forward-looking statements reference NanoAbs pipeline, manufacturing facility, and potential collaborations.
- No new financial guidance, earnings, or material operational updates were provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1611747/000121390023036129/0001213900-23-036129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1611747/000121390023036129/ea177973-8k_biondvax.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-036129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer